• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES SAPIEN 3 TRANSCATHETER HEART VALVE; PROSTHESIS, MITRAL VALVE, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES SAPIEN 3 TRANSCATHETER HEART VALVE; PROSTHESIS, MITRAL VALVE, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9600TFX26
Device Problems Fluid/Blood Leak (1250); Malposition of Device (2616)
Patient Problem Insufficient Information (4580)
Event Date 01/30/2023
Event Type  Injury  
Manufacturer Narrative
The investigation is ongoing.The device remains implanted.
 
Event Description
As reported, it was a valve in valve case of a 26mm sapien 3 valve, in mitral position into a non-edwards surgical valve, by transeptal approach.During procedure, it was not possible to cross septum with the commander delivery system with the valve due to the transeptal hole was too high and the angle was too difficult for the delivery system to cross.Therefore, a new kit was prepared and a new transeptal hole was performed.The valve was implanted but there was severe mitral regurgitation due to low implantation.Therefore, another valve was successfully implanted.The patient was in stable condition post-procedure.
 
Manufacturer Narrative
A supplemental mdr is being submitted for correction and additional information.The following sections of this report have been updated: corrected h.6 investigation conclusions and investigation findings.Added new information to h.6 device codes and type of investigation.The device was not returned to edwards lifesciences for evaluation.Without the device returned for evaluation, visual inspection, functional testing and dimensional analysis were unable to be completed.Imagery was not provided for review.A review of the risk management documentation was performed, and no evidence of product non-conformances or labeling/ifu inadequacies were identified in the evaluation.The complaints were unable to be confirmed due to unavailable relevant medical record and imagery.There was no allegation a device malfunction contributed to this adverse event.A review of ifu/training materials revealed no deficiencies.As reported, ''the valve was implanted but there was severe mitral regurgitation due to low implantation''.Malposition per the instructions for use (ifu), valve malposition requiring intervention is a known potential adverse event associated with the transcatheter heart valve replacement procedure.Per training manual, ''align the outflow of crimped sapien 3 valve 2mm below (towards ventricles) the surgical valve outflow markers'', and ''final sapien 3 valve implant depth should be targeted no more than 20% (atrial) for optimal valve function''.In this case, the valve was deployed at 0:100 a/v position, which may be too low for proper valve function.Paravalvular leak per the instructions for use (ifu), paravalvular leak is a potential adverse event associated with bioprosthetic heart valves and the transcatheter heart valve replacement procedure.In this case, it was likely the low valve deployment leading to the improper seal against the target site, resulting in paravalvular leak.As such, available information suggests that procedural factors (malposition, valve positioning and deployment technique) may have contributed to the complaint event.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.No ifu/labeling/training manual inadequacies were identified.Therefore, no corrective or preventative action nor product risk assessment is required at this time.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SAPIEN 3 TRANSCATHETER HEART VALVE
Type of Device
PROSTHESIS, MITRAL VALVE, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key16397223
MDR Text Key309758092
Report Number2015691-2023-10911
Device Sequence Number1
Product Code NPU
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P140031
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 03/30/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/17/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number9600TFX26
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received03/29/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/14/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age74 YR
-
-